Red Spruce Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.44M | Buy |
|
|||||
|
2025
Q2 | $1.96M | Hold |
|
|||||
|
2025
Q1 | $1.72M | Sell |
|
|||||
|
2024
Q4 | $2.17M | Buy |
|
|||||
|
2024
Q3 | $1.83M | Sell |
|
|||||
|
2024
Q2 | $2.22M | Buy |
|
|||||
|
2024
Q1 | $2.21M | Hold |
|
|||||
|
2023
Q4 | $2.11M | Buy |
|
|||||
|
2023
Q3 | $1.79M | Hold |
|
|||||
|
2023
Q2 | $1.5M | Buy |
|
|||||
|
2023
Q1 | $1.59M | Buy |
|
|||||
|
2022
Q4 | $1.82M | Buy |
|
|||||
|
2022
Q3 | $1.61M | Buy |
|
|||||
|
2022
Q2 | $1.47M | Buy |
|
|||||
|
2022
Q1 | $1.39M | Buy |
|
|||||
|
2021
Q4 | $1.1M | Buy |
|
|||||
|
2021
Q3 | $1.13M | Sell |
|
|||||
|
2021
Q2 | $1.15M | Hold |
|
|||||
|
2021
Q1 | $1.15M | Buy |
|
|||||
|
2020
Q4 | $1.11M | Buy |
|
|||||
|
2020
Q3 | $1.07M | Buy |
|
|||||
|
2020
Q2 | $1.21M | Buy |
|
|||||
|
2020
Q1 | $855K | Sell |
|
|||||
|
2019
Q4 | $1.07M | Buy |
|